Novo Nordisk, the Danish pharmaceutical giant, is taking a new step to address affordability and adherence for patients using its popular weight-loss drugs, Wegovy, and Ozempic. … Read more
Cambridge, MA – Takeda Pharmaceutical Company Limited will reduce its workforce in Cambridge, Massachusetts, by nearly 250 positions, the company announced Friday through a required state … Read more
The global pharmaceutical landscape is undergoing a significant shift, and China is rapidly emerging as a central player. For decades, the United States and Europe have … Read more
WASHINGTON — The White House is actively engaging with pharmaceutical companies, sharing draft legislative text for a policy aimed at lowering prescription drug costs. This move, … Read more
The wait for definitive results from Allogene Therapeutics’ pivotal clinical trial of ALLO-719, an off-the-shelf CAR-T cell therapy for large B-cell lymphoma, is nearing an end. … Read more
The ongoing conflict in the Middle East has, so far, not significantly disrupted the global supply of pharmaceuticals, a critical concern given the potential for geopolitical … Read more
The biotechnology industry gained a fresh perspective this week as Stelios Papadopoulos, widely known as the “godfather of biotech,” participated in an on-stage conversation at STAT’s … Read more
Welcome to Eye on AI, with AI reporter Sharon Goldman. In this edition: OpenAI to acquire startup Astral, expanding push into coding…Fourteen Catholic theologians have filed … Read more
The Food and Drug Administration on Thursday approved a higher dose of Novo Nordisk’s Wegovy, a leading medication for weight loss, as the Danish pharmaceutical company … Read more
Novo Nordisk, the Danish pharmaceutical giant, announced Tuesday a significant reduction in the U.S. List prices for its popular weight-loss drug Wegovy, its diabetes medication Ozempic, … Read more
WASHINGTON — A stark contrast in approaches to pharmaceutical regulation and public health messaging was on display Tuesday at a forum hosted by the Pharmaceutical Research … Read more
WASHINGTON — The Food and Drug Administration on Friday rejected bitopertin, a treatment developed by Disc Medicine for porphyria, a rare genetic disorder that causes extreme … Read more